COVID-19 pharmacy practice related resources for Board licensees.
COVID-19 - Emergency Rules Adopted
- Emergency Rules Adopted March 20, 2020
- Ph 704.15, Ph 1303.01(b), Ph 1104.01(b)
- Extending quantity of prescription drugs dispensed under certain circumstances; extending deadline for CPR certification for pharmacists engaged in the administration of vaccines.
- Ph 704.15, Ph 1303.01(b), Ph 1104.01(b)
- Emergency Rules Adopted April 6, 2020
- Ph 704.03(b)(4)d - Stating that during the pendency of the State of Emergency, pharmacists may accept a faxed-in prescription for a schedule II controlled drug. View Board Guidance Document and DEA Guidelines regarding these temporary emergency provisions during the COVID-19 crisis.
- Ph 707.03, 707.04 - Stating that during the pendency of the State of Emergency, consulting pharmacists do not need pre-approval from the board to act as agents of the board for purposes of destruction of controlled drugs, so long as certain requirements are met. Also temporarily authorizes consulting pharmacists to witness the destruction of controlled substances remotely via videoconferencing.
- Ph 704.03(b)(4)d
- Emergency Rule Adopted April 8, 2020
- Ph 210 - Enabling Board to waive substantive rules as required during to COVID-19 crisis. The Board also issued a Standing Order to allow the Board to act quickly in deciding on waiver requests made under this rule.
- Ph 210
COVID-19 - Executive Orders
- Executive Orders issued by the Governor in response to COVID-19
- Emergency Order issued by NH DHHS on April 3, 2020 regarding chloroquine, hydroxychloroquine, and albuterol inhalers
- Telehealth Emergency Order
- Telehealth FAQ Sheet
- Telehealth OPLC Expansion Guidance
COVID-19 - Federal DEA Controlled Drug Prescription Guidance - National State of Emergency
During this National Emergency the Diversion Control Division will continue to work with its Federal partners, DEA registrants, and their representative association to assure that there is an adequate supply of controlled substances in the United States. The DEA will also work to assure that patients will have access to controlled substances.
On March 16, 2020, the DEA published a COVID-19 Information Page on the Diversion Control Division Website. This page contains important guidance concerning COVID-19 and the national drug supply, electronic prescribing of controlled substances, telemedicine, medicated assisted treatment, and other important federal and state information. This site will be updated frequently as new information and guidance is issued. Please check back frequently for further information.
Please continue to direct all policy questions concerning COVID-19 to the Policy email box at Natural.Disaster@usdoj.gov
COVID-19 - News and Resources
- USP Guidance Document regarding shortage of Personal Protective Equipment (PPE) for sterile
compounding during COVID-19 Pandemic - FDA Guidance Document Regarding Certain REMS Requirements During the COVID-19 Public Health Emergency
- Temporary Policy Regarding Non-Standard PPE Practices for Sterile Compounding by Pharmacy Compounders not Registered as Outsourcing Facilities During the COVID-19 Public Health Emergency -
Guidance for Industry - Online Resources for Dealing with COVID-19 Crisis - Provided by the NH Professionals Health Program
Latest Information on the Coronoavirus (COVID-19) from the CDC and NH DHHS:
Portable Document Format (.pdf). Visit nh.gov for a list of free .pdf readers for a variety of operating systems.
Office of Professional Licensure and Certification
121 South Fruit Street | Concord, NH 03301
Main Telephone: (603) 271-2152